Daniel Herranz

5.7k total citations · 3 hit papers
36 papers, 3.9k citations indexed

About

Daniel Herranz is a scholar working on Molecular Biology, Geriatrics and Gerontology and Physiology. According to data from OpenAlex, Daniel Herranz has authored 36 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Molecular Biology, 13 papers in Geriatrics and Gerontology and 9 papers in Physiology. Recurrent topics in Daniel Herranz's work include Sirtuins and Resveratrol in Medicine (13 papers), RNA modifications and cancer (8 papers) and Adipose Tissue and Metabolism (7 papers). Daniel Herranz is often cited by papers focused on Sirtuins and Resveratrol in Medicine (13 papers), RNA modifications and cancer (8 papers) and Adipose Tissue and Metabolism (7 papers). Daniel Herranz collaborates with scholars based in United States, Spain and Italy. Daniel Herranz's co-authors include Manuel Serrano, Susana Velasco-Miguel, Matthias H. Tschöp, Paul T. Pfluger, Maribel Muñoz‐Martín, Marta Cañamero, Francisca Mulero, Bárbara Martínez-Pastor, Óscar Fernández-Capetillo and Adolfo A. Ferrando and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Daniel Herranz

34 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Sirt1 protects against high-fat diet-induced metabolic damage

2008 782 citations Daniel Herranz, Susana Velasco-Miguel et al. profile →
GLP-1 Agonism Stimulates Brown Adipose Tissue Thermogenesis and Browning Through Hypothalamic AMPK

2014 476 citations Daniel Herranz, Manuel Serrano et al. profile →
Acute lymphoblastic leukaemia

2024 52 citations Sai‐Juan Chen, Daniel Herranz et al. Nature Reviews Disease Primers profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Daniel Herranz United States	24	1.8k	1.3k	1.3k	891	581	36	3.9k
Pablo J. Fernández-Marcos Spain	23	2.3k 1.3×	1.7k 1.3×	866 0.7×	719 0.8×	575 1.0×	40	4.5k
Carlos Sebastián United States	21	1.6k 0.8×	735 0.6×	1.5k 1.2×	824 0.9×	584 1.0×	35	3.3k
Hyun‐Seok Kim South Korea	22	1.5k 0.8×	703 0.5×	1.6k 1.2×	1.1k 1.2×	486 0.8×	76	3.4k
Marı́a M. Fergusson United States	19	3.0k 1.6×	1.5k 1.1×	935 0.7×	1.4k 1.6×	259 0.4×	25	5.1k
Athanassios Vassilopoulos United States	26	2.3k 1.3×	1.3k 1.0×	2.5k 2.0×	1.4k 1.6×	657 1.1×	37	4.6k
Fan Yeung United States	15	1.6k 0.9×	715 0.5×	1.3k 1.0×	637 0.7×	668 1.1×	21	3.6k
Hiroaki Daitoku Japan	22	3.0k 1.6×	768 0.6×	650 0.5×	572 0.6×	534 0.9×	46	4.1k
Hwei-Ling Cheng United States	15	3.0k 1.6×	1.4k 1.1×	2.4k 1.9×	1.1k 1.3×	750 1.3×	23	5.4k
Nathan L. Price United States	26	1.5k 0.8×	908 0.7×	462 0.4×	401 0.5×	208 0.4×	47	3.0k
Jianyuan Luo China	27	1.9k 1.0×	717 0.5×	1.2k 0.9×	737 0.8×	668 1.1×	54	3.4k

Countries citing papers authored by Daniel Herranz

Since Specialization

Citations

This map shows the geographic impact of Daniel Herranz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Herranz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Herranz more than expected).

Fields of papers citing papers by Daniel Herranz

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Herranz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Herranz. The network helps show where Daniel Herranz may publish in the future.

Co-authorship network of co-authors of Daniel Herranz

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Herranz. A scholar is included among the top collaborators of Daniel Herranz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Herranz. Daniel Herranz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Silva-Diz, Victoria da, Maya Aleksandrova, Oekyung Kim, et al.. (2025). A feedforward loop between ACLY and MYC supports T-ALL progression in vivo. PubMed. 2(2). 100069–100069. 1 indexed citations

Silva-Diz, Victoria da & Daniel Herranz. (2025). Unleashing the Full Potential of Metabolic Interventions in T-ALL. Blood Cancer Discovery. 6(3). 163–167.

Bartman, Caroline, Shengqi Hou, Fabian Correa, et al.. (2025). Systemic metabolic changes in acute and chronic lymphocytic choriomeningitis virus infection. Molecular Metabolism. 99. 102194–102194. 2 indexed citations

Chen, Sai‐Juan, Daniel Herranz, Cristina Mecucci, et al.. (2024). Acute lymphoblastic leukaemia. Nature Reviews Disease Primers. 10(1). 41–41. 52 indexed citations breakdown →

Andrieu, Guillaume P., Guillaume Hypolite, Caroline Costa, et al.. (2024). ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development. Blood Advances. 9(7). 1670–1691.

Silva-Diz, Victoria da, Maya Aleksandrova, Shirley Luo, et al.. (2022). A Therapeutically Targetable NOTCH1–SIRT1–KAT7 Axis in T-cell Leukemia. Blood Cancer Discovery. 4(1). 12–33. 8 indexed citations

Werlen, Guy, Meiling Li, Victoria da Silva-Diz, et al.. (2022). Dietary glucosamine overcomes the defects in αβ-T cell ontogeny caused by the loss of de novo hexosamine biosynthesis. Nature Communications. 13(1). 7404–7404. 10 indexed citations

Silva-Diz, Victoria da, Bin Cao, Eric Chiles, et al.. (2021). A novel and highly effective mitochondrial uncoupling drug in T-cell leukemia. Blood. 138(15). 1317–1330. 8 indexed citations

Herranz, Daniel, et al.. (2018). The MYC Enhancer-ome: Long-Range Transcriptional Regulation of MYC in Cancer. Trends in cancer. 4(12). 810–822. 90 indexed citations

10.

Ambesi‐Impiombato, Alberto, Yue Qin, Daniel Herranz, et al.. (2017). Synergistic antileukemic therapies in NOTCH1-induced T-ALL. Clinical Cancer Research. 23(24). 65–66. 1 indexed citations

11.

Herranz, Daniel, Alberto Ambesi‐Impiombato, Jessica Sudderth, et al.. (2015). Metabolic reprogramming induces resistance to anti-NOTCH1 therapies in T cell acute lymphoblastic leukemia. Nature Medicine. 21(10). 1182–1189. 160 indexed citations

12.

Herranz, Daniel, Alberto Ambesi‐Impiombato, Teresa Palomero, et al.. (2014). A NOTCH1-driven MYC enhancer promotes T cell development, transformation and acute lymphoblastic leukemia. Nature Medicine. 20(10). 1130–1137. 303 indexed citations

13.

Lobo, Víctor J. Sánchez‐Arévalo, Andreia V. Pinho, Amanda Mawson, et al.. (2013). Sirtuin-1 Regulates Acinar-to-Ductal Metaplasia and Supports Cancer Cell Viability in Pancreatic Cancer. Cancer Research. 73(7). 2357–2367. 61 indexed citations

14.

Maraver, Antonio, Pablo J. Fernández-Marcos, Daniel Herranz, et al.. (2012). Therapeutic Effect of γ-Secretase Inhibition in KrasG12V-Driven Non-Small Cell Lung Carcinoma by Derepression of DUSP1 and Inhibition of ERK. Cancer Cell. 22(2). 222–234. 89 indexed citations

15.

Herranz, Daniel, Antonio Maraver, Marta Cañamero, et al.. (2012). SIRT1 promotes thyroid carcinogenesis driven by PTEN deficiency. Oncogene. 32(34). 4052–4056. 63 indexed citations

16.

Gambini, Juan, Mari Carmen Gómez‐Cabrera, Consuelo Borrás, et al.. (2011). Free [NADH]/[NAD+] regulates sirtuin expression. Archives of Biochemistry and Biophysics. 512(1). 24–29. 41 indexed citations

17.

Herranz, Daniel, et al.. (2011). Limited role of Sirt1 in cancer protection by dietary restriction. Cell Cycle. 10(13). 2215–2217. 16 indexed citations

18.

Campagna, Michela, Daniel Herranz, María Ángel García, et al.. (2010). SIRT1 stabilizes PML promoting its sumoylation. Cell Death and Differentiation. 18(1). 72–79. 49 indexed citations

19.

Efeyan, Alejo, Ana Ortega-Molina, Susana Velasco-Miguel, et al.. (2007). Induction of p53-Dependent Senescence by the MDM2 Antagonist Nutlin-3a in Mouse Cells of Fibroblast Origin. Cancer Research. 67(15). 7350–7357. 105 indexed citations

20.

Efeyan, Alejo, Isabel García‐Cao, Daniel Herranz, Susana Velasco-Miguel, & Manuel Serrano. (2006). Policing of oncogene activity by p53. Nature. 443(7108). 159–159. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact